Please login to the form below

Not currently logged in


This page shows the latest ophthalmology news and features for those working in and with pharma, biotech and healthcare.

Takeda sells blockbuster-in-waiting Xiirda to Novartis for $5.3bn

Takeda sells blockbuster-in-waiting Xiirda to Novartis for $5.3bn

Given that Takeda did not have a presence in ophthalmology prior to the Shire acquisition, Shire’s Xiidra would have represented a new market for Takeda, but also a market that ... As a result, Takeda had to take on a significant amount of debt to

Latest news

More from news
Approximately 8 fully matching, plus 98 partially matching documents found.

Latest Intelligence

  • Diagnosed Anywhere Diagnosed Anywhere

    The diagnostic report includes treatment advice aligned with the American Academy of Ophthalmology’s preferred practice pattern for diabetic retinopathy.

  • Deal Watch October 2018

    Sandoz’s US business has retained its biosimilars, value‐added medicines and complex generics, including the ophthalmology products.

  • Deal Watch January 2018

    Collaboration, licence. 830. Molecular Partners/ Allergan. Option exercise for 2 DARPins from Allergan's ophthalmology alliance signed in 2012.

  • The good, the bad and the ugly The good, the bad and the ugly

    Ophthalmology. Ophthalmology is dominated by a small number of the same therapies marketed by different companies in different regions; Regeneron, Bayer and Santen all market Eylea, whereas Novartis and Roche market ... Biogen was the largest seller in

  • Deal Watch - May 2017 Deal Watch - May 2017

    products with a focus on ophthalmology will cost $4.75bn representing 12 x EBITDA.  Since 2013 Akorn has been on a spending spree buying US rights to timolol and other ophthalmics

More from intelligence
Approximately 2 fully matching, plus 19 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 28 partially matching documents found.

Latest from PMHub

  • emotive adds to medical team with new Scientific Lead and Associate Medical Writer

    Kate is experienced in a wide range of therapy areas, including immunology, specifically Crohn’s disease, ulcerative colitis and psoriatic arthritis, in ophthalmology, including retinal diseases, glaucoma and dry eye disease,

  • PRMA Consulting Ltd

    Our experience encompasses a wide range of indications, including; cardiovascular and renal, gastroenterology, immunology, infectious diseases and vaccines, metabolism and endocrinology, neurology and psychiatry, oncology/hematology, ophthalmology,

  • Wilmington Healthcare appoints new Account Director

    His final post at the company was Brand Lead, Ophthalmology.  Before joining Novartis, Gareth held senior sales and product manager positions at Gilead Sciences Ltd in their anti-infective franchise.

  • Leading Edge bolsters its delivery team

    ophthalmology, cardiovascular disease and neuroscience. "I enjoy working with both patients and healthcare professionals, to really get to understand their challenges and provide solutions that ultimately lead to improved outcomes", she

  • Hayward Medical Communications launch a new, eye-opening journal

    Ophthalmology in practice will also feature case studies, patient viewpoints, and service development and guidance updates. ... Ophthalmology in practice is a free resource for healthcare professionals in the UK.

More from PMHub
Approximately 1 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...